Literature DB >> 16834879

Mumps in a boarding school: description of an outbreak and control measures.

Douglas G Mackenzie1, George Craig, Nicholas F Hallam, Janelle Moore, Janet Stevenson.   

Abstract

BACKGROUND: The number of cases of mumps in the UK has increased during 2004-2005. Understanding why some people are more susceptible to mumps infection will help target vaccination and other control measures in the future. This paper describes a mumps outbreak in a boarding school in Scotland (October to November 2004).
OBJECTIVES: To describe the characteristics of cases in a mumps outbreak; and to conduct a case-control study looking at the effect of previous measles-mumps-rubella (MMR) vaccination.
DESIGN: Descriptive epidemiology. DATA SOURCES: Clinical, laboratory and surveillance data.
SETTING: A private school with 600 boarding and day pupils.
RESULTS: Fifty cases were notified to the public health department as having mumps. Twenty of the cases (40%) were confirmed virologically, all born between 1987-1991. A matched case-control study was conducted to explore the effect of prior MMR vaccination. Compared to no vaccine, MMR protected against mumps (odds ratio = 0.7), two doses offering best protection (odds ratio = 0.5), but the study was not large enough to detect a statistically significant difference.
CONCLUSION: Some children and young people in the UK are currently incompletely vaccinated. This outbreak illustrates the potential of a mumps outbreak to disrupt the medical, educational and social life of a school. All children should be vaccinated with two doses of MMR vaccine before school entry. Children and young people born between 1979-1991 should be given the necessary additional dose(s) of MMR vaccine.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16834879      PMCID: PMC1872063     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  4 in total

1.  UK and Italy have low MMR uptake.

Authors:  Fiona Fleck
Journal:  BMJ       Date:  2003-11-15

2.  TV programme raises fresh allegations about MMR doctor.

Authors:  Trevor Jackson
Journal:  BMJ       Date:  2004-11-27

3.  Saliva antibody testing and vaccination in a mumps outbreak.

Authors:  M E Ramsay; D W Brown; H R Eastcott; N T Begg
Journal:  CDR (Lond Engl Rev)       Date:  1991-08-16

4.  An outbreak of mumps in the metropolitan area of Walsall, UK.

Authors:  R Nicholas Pugh; Bolanle Akinosi; Shalini Pooransingh; Jagdish Kumar; Sharon Grant; Emma Livesley; John Linnane; Sam Ramaiah
Journal:  Int J Infect Dis       Date:  2002-12       Impact factor: 3.623

  4 in total
  6 in total

1.  Outbreak of mumps in a school setting, United Kingdom, 2013.

Authors:  Erlend T Aasheim; Thomas Inns; Amy Trindall; Lynsey Emmett; Kevin E Brown; Chris J Williams; Mark Reacher
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 2.  Vaccines for measles, mumps and rubella in children.

Authors:  Vittorio Demicheli; Alessandro Rivetti; Maria Grazia Debalini; Carlo Di Pietrantonj
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

Review 3.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2021-11-22

4.  An outbreak of mumps with genetic strain variation in a highly vaccinated student population in Scotland.

Authors:  L J Willocks; D Guerendiain; H I Austin; K E Morrison; R L Cameron; K E Templeton; V R F DE Lima; R Ewing; W Donovan; K G J Pollock
Journal:  Epidemiol Infect       Date:  2017-09-14       Impact factor: 4.434

5.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2020-04-20

6.  Recurrent outbreaks of mumps in Lothian and the impact of waning immunity.

Authors:  C J Waugh; L J Willocks; K Templeton; J Stevenson
Journal:  Epidemiol Infect       Date:  2020-06-18       Impact factor: 2.451

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.